Britta Tarp Selected Research

Britta Tarp Research Topics

4	Fibrosis (Cirrhosis) 01/2021 - 01/2017
4	Chronic Hepatitis C 01/2021 - 01/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 08/2018
3	Infections 01/2020 - 01/2014
2	Pneumonia (Pneumonitis) 03/2021 - 02/2021
2	Liver Diseases (Liver Disease) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 08/2018
2	Schistosomiasis (Bilharziasis) 08/2017 - 01/2009
1	Peliosis Hepatis 09/2013

5	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
3	InterferonsIBA 08/2018 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 02/2021
2	SofosbuvirIBA 01/2020 - 08/2018
2	AntibodiesIBA 08/2017 - 01/2009
2	Ribavirin (Virazole)FDA LinkGeneric 02/2015 - 01/2014
1	Complement C4 (Complement Component 4)IBA 01/2021
1	Complement C3 (C3 Complement)IBA 01/2021
1	CollagenIBA 01/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2018
1	Immunoglobulin E (IgE)IBA 08/2017
1	Antimalarials (Antimalarial Agents)IBA 08/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2014
1	telaprevirIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2014
1	Oral ContraceptivesIBA 09/2013